Some price data may be temporarily unavailable.
The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
Proteonomix, Inc. is a biotechnology company, which engages in the discovery and development of stem cell therapeutic and cosmeceutical products. It develops pre clinical-stage therapeutic agents and treatments for diabetes, heart and lung diseases. The company was founded by Michael Moshe Cohen on June 26, 1995 and is headquartered in Paramus, NJ.
No news articles found for Proteonomix.
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
